Starpharma Holdings Limited
Starpharma Holdings Limited
Your view on SPL.AX
Overview
What the company does, where it operates, and who runs it.
About Starpharma Holdings Limited
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Cheryl Maley
- Headquarters
- 4-6 Southampton Crescent, Abbotsford, VIC, AU
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Cheryl Maley
- Headquarters
- 4-6 Southampton Crescent, Abbotsford, VIC, AU
Starpharma Holdings Limited is a biopharmaceutical enterprise focused on the research, development, and global commercialization of dendrimer-based products for the pharmaceutical, life sciences, and other industries. Its current offerings include VivaGel, a non-antibiotic treatment and preventative measure for bacterial vaginosis.
The company also provides the antiviral VivaGel condom and VIRALEZE, an antiviral nasal spray. Furthermore, Starpharma is actively progressing its DEP (dendrimer drug delivery) technology platform.
This platform supports multiple oncology candidates in clinical development, such as DEP docetaxel (Phase 2), DEP cabazitaxel (Phase 2), DEP gemcitabine (Phase 1/2), and DEP irinotecan (Phase 2), all aimed at treating cancer.
The DEP technology is also being applied to radiotheranostics for cancer diagnosis and therapy, Antibody Drug Conjugates (including DEP HER-2 ADC), and non-oncology programs. Additionally, DEP AZD0466 is currently in Phase 1/2 clinical trials for haematological malignancies.
Founded in 1996, the company maintains its headquarters in Abbotsford, Australia.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Starpharma Holdings Limited. Starting points for Starpharma Holdings Limited: EPS -AUD 0.02, beta 0.75 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Starpharma Holdings Limited. Starpharma Holdings Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Starpharma Holdings Limited. Trailing twelve-month EPS for Starpharma Holdings Limited stands at -AUD 0.02. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Starpharma Holdings Limited. Starpharma Holdings Limited has reported as a listed company since 2000. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| ODTXOdyssey Therapeutics, Inc. | Healthcare | NASDAQ | $815.2M | ||
| OGENOragenics, Inc. | Healthcare | AMEX | $708,377 | ||
| OKUROnKure Therapeutics, Inc. | Healthcare | NASDAQ | $109.4M | ||
| OKYOOKYO Pharma Limited | Healthcare | NASDAQ | $56.2M | ||
| OLMAOlema Pharmaceuticals, Inc. | Healthcare | NASDAQ | $615.0M | ||
| OMEROmeros Corporation | Healthcare | NASDAQ | $983.7M | ||
| ONCBeOne Medicines Ltd. | Healthcare | NASDAQ | $41.8B | ||
| ONCOOnconetix, Inc. | Healthcare | NASDAQ | $1.0M | ||
| ONCO.NEOnco-Innovations Limited | Healthcare | NEO | — | ||
| ONCSQOncoSec Medical Incorporated | Healthcare | OTC | $596 | ||
| ONCYOncolytics Biotech Inc. | Healthcare | NASDAQ | $35.1M | ||
| ONPHOncology Pharma Inc. | Healthcare | OTC | $109,553 | ||
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Starpharma Holdings Limited. Coverage tracks Starpharma Holdings Limited within Biotechnology (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Starpharma Holdings Limited.